Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells

British Journal of Cancer

Volumn 107, Issue 10, 2012, Pages 1737-1744

  Tawadros, T ^a   Brown, M D ^a   Hart, C A ^a   Clarke, N W ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Bone marrow endothelial cells; Bone marrow stroma; Ephrin A2; Metastasis; Omega 6; Prostate cancer

Indexed keywords

ARACHIDONIC ACID; EPHRIN RECEPTOR A2; FOCAL ADHESION KINASE; LIGAND; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ARTICLE; BONE MARROW; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID RAFT; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIUM; EPHRIN-A1; FATTY ACIDS, OMEGA-6; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENES, SRC; HUMANS; LIGANDS; MALE; MESENCHYMAL STROMAL CELLS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPHA2; SIGNAL TRANSDUCTION;

EID: 84869096283     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.457     Document Type: Article

References (40)

1. Aronson WJ, Barnard RJ, Freedland SJ, Henning S, Elashoff D, Jardack PM, Cohen P, Heber D, Kobayashi N (2010) Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol 183: 345-350.
2. Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, Oxley JD, Nobes CD (2010) Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol 12: 1194-1204.
3. Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, HarperW(2004) High levels of phosphorylated form of Akt-1. in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 10: 6572-6578. (Pubitemid 39346553)
4. Brown MD, Hart C, Gazi E, Gardner P, Lockyer N, Clarke N (2010) Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Br J Cancer 102: 403-413.
5. Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW (2006) Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer 94: 842-853.
6. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ (2000) Metastatic patterns of prostate cancer: An autopsy study of 1589 patients. Hum Pathol 31: 578-583. (Pubitemid 30323983)
7. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J (2007) A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16: 1364-1370. (Pubitemid 47076865)
8. Crawford ED (2003) Epidemiology of prostate cancer. Urology 62: 3-12. (Pubitemid 38050194)
9. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) EphA2: A determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene 23: 1448-1456. (Pubitemid 38406840)
10. Fang WB, Ireton RC, Zhuang G, Takahashi T, Reynolds A, Chen J (2008) Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci 121: 358-368. (Pubitemid 351356707)
11. Franks LM (1954) Latent carcinoma of the prostate. J Pathol Bacteriol 68: 603-616.
12. Gazi E, Gardner P, Lockyer NP, Hart CA, Brown MD, Clarke NW(2007) Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res 48: 1846-1856. (Pubitemid 47312000)
13. Hart CA, Brown M, Bagley S, Sharrard M, Clarke NW (2005) Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer 92: 503-512. (Pubitemid 40395531)
14. Honn KV, Tang DG (1992) Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 11: 353-375.
15. Ihara Y, Inai Y, Ikezaki M (2011) Alteration of integrin-dependent adhesion and signaling in EMT-like MDCK cells established through overexpression of calreticulin. J Cell Biochem 112: 2518-2528.
16. Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J (2001) Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15: 1953-1962. (Pubitemid 32848799)
17. Kreisberg JI, Malik SN, Prihoda TJ, Bedolla RG, Troyer DA, Kreisberg S, Ghosh PM (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res 64: 5232-5236. (Pubitemid 39006542)
18. Li J, Ballif BA, Powelka AM, Dai J, Gygi SP, Hsu VW (2005) Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev Cell 9: 663-673. (Pubitemid 41555148)
19. Loberg RD, Logothetis CJ, Keller ET, Pienta KJ (2005) Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J Clin Oncol 23: 8232-8241. (Pubitemid 46211560)
20. Macdonald JL, Pike LJ (2005) A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 46: 1061-1067.
21. Miao H, Burnett E, Kinch M, Simon E, Wang B (2000) Activation of EphA2. kinase suppresses integrin function and causes focal-Adhesion-kinase dephosphorylation. Nat Cell Biol 2: 62-69.
22. Miao H, Li DQ, Mukherjee A, Guo H, Petty A, Cutter J, Basilion JP, Sedor J, Wu J, Danielpour D, Sloan AE, Cohen ML, Wang B (2009) EphA2. mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16: 9-20.
23. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
24. Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133: 38-52. (Pubitemid 351442996)
25. Pike LJ, Han X, Chung KN, Gross RW (2002) Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: A quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41: 2075-2088. (Pubitemid 34132282)
26. Schaller MD (2010) Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci 123: 1007-1013.
27. Schumacher MC, Laven B, Petersson F, Cederholm T, Onelov E, Ekman P, Brendler C (2011) A comparative study of tissue omega-6 and omega-3. polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimens. Urol Oncol; e-pub ahead of print 31 March 2011; doi:10.1016/j.urolonc.2011.01.014.
28. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH (2001) Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 84: 1417-1423. (Pubitemid 32522114)
29. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63: 963-966.
30. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny P, Waldhausl W (2001) Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 276: 37335-37340.
31. Summy JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22: 337-358. (Pubitemid 36791891)
32. Szymanski KM, Wheeler DC, Mucci LA (2010) Fish consumption and prostate cancer risk: A review and meta-Analysis. Am J Clin Nutr 92: 1223-1233.
33. Taddei ML, Parri M, Angelucci A, Bianchini F, Marconi C, Giannoni E, Raugei G, Bologna M, Calorini L, Chiarugi P (2011) EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells. Mol Cancer Res 9: 149-160.
34. Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P (2009) Kinasedependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol 174: 1492-1503.
35. Tatarov O, Mitchell TJ, Seywright M, Leung HY, Brunton VG, Edwards J (2009) SRC family kinase activity is up-regulated in hormone-refractory prostate cancer. Clin Cancer Res 15: 3540-3549.
36. Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman Jr CA (2007) Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. J Clin Oncol 25: 3076-3081. (Pubitemid 47218054)
37. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS (1999) Overexpression of the EphA2. tyrosine kinase in prostate cancer. Prostate 41: 275-280.
38. Warburg O, Wind F, Negelein E (1927) The Metabolism of Tumors in the Body. J Gen Physiol 8: 519-530.
39. Wynder EL, Rose DP, Cohen LA (1994) Nutrition and prostate cancer: A proposal for dietary intervention. Nutr Cancer 22: 1-10. (Pubitemid 24233872)
40. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR (2005) Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115: 959-968(Pubitemid 40489400)